Viewing Study NCT05022394

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-05-23 @ 9:56 AM
Study NCT ID: NCT05022394
Status: WITHDRAWN
Last Update Posted: 2022-05-27
First Post: 2020-04-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Non-Small Cell Carcinoma View
None Recurrent Lung Non-Small Cell Carcinoma View
None Stage I Lung Cancer AJCC v8 View
None Stage II Lung Cancer AJCC v8 View
None Stage IIA Lung Cancer AJCC v8 View
None Stage IIB Lung Cancer AJCC v8 View
None Stage III Lung Cancer AJCC v8 View
None Stage IIIA Lung Cancer AJCC v8 View
None Stage IIIB Lung Cancer AJCC v8 View
None Stage IIIC Lung Cancer AJCC v8 View
None Stage IV Lung Cancer AJCC v8 View
None Stage IVA Lung Cancer AJCC v8 View
None Stage IVB Lung Cancer AJCC v8 View
Keywords: